The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Stephen V. Liu, Vijendra K. Singh et al.|Clinical Lung Cancer|2021Cited by 30
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Misako Nagasaka, Asfar S. Azmi, Mohammad Asad et al.|Lung Cancer|2021Cited by 15
Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomasRobert Hsu, Jorge J. Nieva, Rong‐Fu Wang et al.|Oncotarget|2021Cited by 12
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non–Small-Cell Lung CancerAbdul Rafeh Naqash, Hirva Mamdani, Charalampos S. Floudas et al.|JCO Precision Oncology|2024Cited by 5
Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).Stephen V. Liu, Hossein Borghaei, Ari M. Vanderwalde et al.|Journal of Clinical Oncology|2020Cited by 5